Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 30

Results For "Inc"

7907 News Found

Shaquille O’Neal partners with Lilly in National Awareness push for Zepbound
News | June 11, 2026

Shaquille O’Neal partners with Lilly in National Awareness push for Zepbound

The campaign aims to raise awareness of a condition that affects an estimated 24 million adults in the US, many of whom remain undiagnosed


Thyrocare expands in UP with new Prayagraj lab to boost diagnostic access
News | June 11, 2026

Thyrocare expands in UP with new Prayagraj lab to boost diagnostic access

The Prayagraj lab is designed to handle both routine and specialised testing


DFE Pharma wins third straight EcoVadis Gold Medal
News | June 11, 2026

DFE Pharma wins third straight EcoVadis Gold Medal

The award places the company in the top 5% globally


Dr. Alka Rao becomes first woman director of CSIR-IMTECH
People | June 11, 2026

Dr. Alka Rao becomes first woman director of CSIR-IMTECH

Accomplished molecular microbiologist and protein engineer takes charge of CSIR-IMTECH after serving in key scientific and regulatory leadership roles at FSSAI


Malabar Group partners with Institute of Palliative Medicine to launch Malabar Care Connect
Healthcare | June 11, 2026

Malabar Group partners with Institute of Palliative Medicine to launch Malabar Care Connect

Digital platform aims to expand access to palliative care through teleconsultations, training, community engagement and global knowledge-sharing


Sygnature Discovery partners with DaltonTx to enhance AI-driven drug discovery capabilities
Digitisation | June 11, 2026

Sygnature Discovery partners with DaltonTx to enhance AI-driven drug discovery capabilities

Collaboration aims to accelerate medicinal chemistry decision-making, reduce synthesis burden and strengthen data-secure AI adoption in drug discovery


AstraZeneca gets CDSCO nod for Trastuzumab Deruxtecan plus Pertuzumab
Drug Approval | June 11, 2026

AstraZeneca gets CDSCO nod for Trastuzumab Deruxtecan plus Pertuzumab

Approval expands treatment options for patients with unresectable or metastatic HER2-positive breast cancer


GSK bets big on oncology with $10.6 billion Nuvalent acquisition
News | June 10, 2026

GSK bets big on oncology with $10.6 billion Nuvalent acquisition

Deal brings late-stage lung cancer candidates zidesamtinib and neladalkib into GSK’s portfolio


Ten years on, PMSMA continues to shape safer motherhood in India
Policy | June 10, 2026

Ten years on, PMSMA continues to shape safer motherhood in India

7.5 crore antenatal check-ups and 1.2 crore high-risk pregnancies identified under flagship programme as maternal and neonatal mortality declines


Johnson & Johnson to acquire Firefly Bio in $1 billion oncology push
Biotech | June 10, 2026

Johnson & Johnson to acquire Firefly Bio in $1 billion oncology push

The acquisition reflects Johnson & Johnson’s push to strengthen its position in antibody engineering and next-generation oncology modalities